Mogamulizumab in the treatment of advanced mycosis fungoides and Sézary syndrome: safety and efficacy-Reference-Cited by-同舟云学术

Mogamulizumab in the treatment of advanced mycosis fungoides and Sézary syndrome: safety and efficacy

Published:2020-04-28 Issue:6 Volume:20 Page:447-452
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Lewis Daniel J.¹^ORCID,Rook Alain H.²

Affiliation:

1. Cutaneous Oncology Fellow, Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA

2. Professor of Dermatology and Director of Cutaneous Lymphoma Program, Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA

Funder

funding

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2020.1760096

Reference50 articles.

1. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

2. Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis

3. Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy

4. Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma

5. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Real-World Effectiveness of Mogamulizumab: A Narrative Review;International Journal of Molecular Sciences;2024-02-12

2. Mogamulizumab Multimodality Therapy with Systemic Retinoids, Interferon, or Extracorporeal Photopheresis for Advanced Cutaneous T-Cell Lymphoma;Dermatologic Therapy;2023-12-19

3. Alopecia areata-like presentations with mogamulizumab therapy;JAAD Case Reports;2023-11

4. Unveiling the hidden struggles: Exploring the profound impact of advanced stage cutaneous T‐cell lymphoma on quality of life;Skin Health and Disease;2023-10-26

5. [¹⁸F]FDG PET/CT in a Case of Mycosis Fungoides Showing an Unusual Adverse Reaction to Mogamulizumab: Correlation Between Imaging and Histological Findings;Cancer Biotherapy and Radiopharmaceuticals;2023-05-01